Abivax stock rockets 30% on Eli Lilly takeover speculation
Abivax stock (EPA: ABVX) surged roughly 30% in early Paris trading Monday after French media reported that US pharmaceutical giant Eli Lilly was preparing a €15 billion ($17.5 billion) acquisition offer for the French biotech. The move would value the company at nearly double its current market capitalization and cap an extraordinary year of gains
